If you didn't find what you were looking for, try a new search!
LOWELL, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased [...]
LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) – Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced [...]
Rapid Micro Biosystems raises $81M to continue global expansion of automated pharmaceutical QC platform to improve data integrity and safety in biologics, vaccines, and cell & gene therapy manufacturing LOWELL, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, [...]
Interview with Robert Spignesi, CEO of Rapid Micro Biosystems In May 2020 Rapid Micro Biosystems raised USD 120m to expand global commercialization of its Growth Direct™ automated microbial detection platform, with Endeavour Vision joining as a new investor. In this [...]
Proceeds will enable the company to meet growing demand for its automated microbial detection platform, currently used by a majority of the top 20 global biopharmaceutical companies, and support new product development for pandemic response. Global investor syndicate is led by [...]